✦ LIBER ✦

Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade®) in chemotherapy-naïve patients with advanced stage non-small cell lung cancer (NSCLC)

✍ Scribed by Li, Tianhong; Ho, Liawaty; Piperdi, Bilal; Elrafei, Tarek; Camacho, Fernando J.; Rigas, James R.; Perez-Soler, Roman; Gucalp, Rasim

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-101 XYOTAX™/carboplatin vs paclitaxel/

✍ Langer, C.; O'Byrne, K.; Ross, H.; Socinski, M.; Szczesna, A.; Dediu, M.; Orlov, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 136 KB

A phase I and pharmacologic study of seq

✍ Cynthia Ma; Sumithra J. Mandrekar; Steven R. Alberts; Gary A. Croghan; Aminah Ja 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 310 KB

Phase II study of erlotinib for chemothe

✍ Dae Ho Lee; Sang-We Kim; Cheolwon Suh; Yun Hee Han; Jung-Shin Lee 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 241 KB

P-562 Evaluation of bexarotene (Targreti

✍ Ramlau, R.; Zatloukal, P.; Tadokoro, H.; Jassem, J.; Hao, D.; Orlov, S.; Gottfri 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

O-104 XYOTAXT™ vs. gemcitabine or vinore

✍ O'Brien, M.; Sandler, A.; Popovich, A.; Ganchev, H.; Bogdanova, N.; Miziara, J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 143 KB

34 Phase II study of LY231514 in patient

✍ Clarke, S.; Boyer, M.; Millward, M.; Findlay, M.; Ackland, S.; Childs, A.; Brew, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 161 KB